Stevanato Group (NYSE:STVN – Get Free Report) issued its earnings results on Tuesday. The company reported €0.12 ($0.13) earnings per share for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)), Briefing.com reports. Stevanato Group had a return on equity of 10.89% and a net margin of 11.27%. The company had revenue of €277.90 million for the quarter, compared to analyst estimates of €274.36 million. During the same quarter in the previous year, the company posted $0.16 earnings per share. The company’s quarterly revenue was up 2.4% compared to the same quarter last year. Stevanato Group updated its FY 2024 guidance to 0.517-0.539 EPS and its FY24 guidance to €0.47-0.49 EPS.
Stevanato Group Trading Down 0.0 %
Shares of NYSE STVN traded down €0.01 ($0.01) on Thursday, hitting €22.54 ($24.77). The company’s stock had a trading volume of 164,673 shares, compared to its average volume of 509,713. Stevanato Group has a 12-month low of €16.56 ($18.20) and a 12-month high of €34.73 ($38.16). The company has a quick ratio of 1.13, a current ratio of 1.74 and a debt-to-equity ratio of 0.19. The stock has a 50 day moving average of €19.66 and a 200-day moving average of €20.31.
Wall Street Analyst Weigh In
Several research analysts have weighed in on STVN shares. Citigroup lowered their target price on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Morgan Stanley lowered their target price on shares of Stevanato Group from $26.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Monday, July 15th.
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Stories
- Five stocks we like better than Stevanato Group
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Roth IRA Calculator: Calculate Your Potential Returns
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
